G

lobal spending on pharmaceuticals is forecast to reach $1.5 trillion by 2021, a whopping 32 percent increase from expected spending this year. Even so, the year-on-year rate of increase is expected to be less than it has been in the recent past, when new, high-priced medicines for treating hepatitis C and some cancers prompted a huge uptick in demand.

Indeed, overall spending will rise nearly 1.5 times faster between 2017 and 2021 than between 2012 and 2016, growing by $367 billion compared with $148 billion. But spending is forecast to drop 9 percent in 2016 from the past two years, which represented nearly unprecedented spending growth, and reach anywhere from 4 percent to 7 percent, on a compounded annual basis, between now and 2021.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.